Growth Metrics

Hyperfine (HYPR) EBITDA Margin (2021 - 2026)

Hyperfine posted quarterly EBITDA Margin of 219.27% for Q1 2026, up 29089.0% year-on-year from N/an in Q1 2025, and down 51.35% on a QoQ basis from 144.87% in Q4 2025.

Hyperfine (HYPR) has 6 years of EBITDA Margin data on file, last reported at 219.27% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin rose 29089.0% year-over-year to 219.27%; the trailing twelve-month figure through Mar 2026 stood at 226.64% (up 14394.0% YoY), and the FY2025 full-year result was 273.43%, up 6190.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 219.27%, down from 144.87% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 144.87% in Q4 2025 and bottomed at 1575.28% in Q1 2022.
  • The 5-year median for EBITDA Margin is 432.95% (2023), against an average of 545.02%.
  • The widest annual swing landed in 2022, when EBITDA Margin surged 502616 bps; it then slumped 18694 bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 957.09% in 2022, then soared by 55 bps to 432.95% in 2023, then declined by 7 bps to 463.81% in 2024, then surged by 69 bps to 144.87% in 2025, then slumped by 51 bps to 219.27% in 2026.
  • The last three EBITDA Margin figures came in at 219.27% (Q1 2026), 144.87% (Q4 2025), and 259.53% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Hyperfine 149.47 Mn 108.20 Mn 1.98 Mn -219.27%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -219.27%
Dec 31, 2025 -144.87%
Sep 30, 2025 -259.53%
Jun 30, 2025 -355.90%
Mar 31, 2025 -510.15%
Dec 31, 2024 -463.81%
Sep 30, 2024 -300.93%
Jun 30, 2024 -298.71%
Mar 31, 2024 -323.22%
Dec 31, 2023 -432.95%
Sep 30, 2023 -504.68%
Jun 30, 2023 -345.81%
Mar 31, 2023 -494.69%
Dec 31, 2022 -957.09%
Sep 30, 2022 -565.67%
Jun 30, 2022 -1,512.85%
Mar 31, 2022 -1,575.28%
Dec 31, 2021 -5,983.26%
Sep 30, 2021 -4,417.79%
Jun 30, 2021 -4,074.30%
Mar 31, 2021 -2,358.01%